Synchronous double primary hepatocellular carcinoma and intrahepatic cholangiocarcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Synchronous double primary hepatocellular carcinoma and intrahepatic cholangiocarcinoma

Published:2021-11-19 Issue:46 Volume:100 Page:e27349
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Qu Meng-Meng,Zhu Yuan-Hui,Li Yi-Xiang,Li Zhi-Fan,Li Jin-Kui,Xu Yong-Sheng,Shrestha Manishkumar,Lei Jun-Qiang

Funder

Intra-hospital Fund of the First Hospital of Lanzhou University

Lanzhou Science and Technology Plan Project of Chengguan District

Lanzhou Science and Technology Development Guiding Plan Project of Lanzhou

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference36 articles.

1. Diagnosis of digestive system tumours;Washington;Int J Cancer,2021

2. Double primary liver cancer (intrahepatic cholangiocarcinoma and hepatocellular carcinoma) in a patient with hepatitis C virus-related cirrhosis;Inaba;J Hepatobiliary Pancreat Surg,2007

3. Clinicopathologic features and prognosis of combined hepatocellular cholangiocarcinoma;Koh;Am J Surg,2005

4. Synchronous development of intrahepatic cholangiocarcinoma and hepatocellular carcinoma in different sites of the liver with chronic B-viral hepatitis: two case reports;Jung;BMC Res Notes,2013

5. Combined liver cell and bile duct carcinoma;Allen;Am J Pathol,1949

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synchronous presentation of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: Report of an exceptional case with review of the literature;International Journal of Surgery Case Reports;2024-01

2. An unresectable and metastatic intrahepatic cholangiocarcinoma with EML4-ALK rearrangement achieving partial response after first-line treatment with ensartinib: a case report;Frontiers in Oncology;2023-08-22

3. Efficacy of Lipid Nanoparticle-Loaded Sorafenib Combined with Hepatic Artery Chemoembolization in the Treatment of Primary Hepatocellular Carcinoma Complicated with Microvascular Invasion;Disease Markers;2022-05-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3